Poor
Mostly Not Aligned
Patient Risk:
Moderate
Summary
Most claims made about taking aspirin (food/no food effects, timing, urgent-care triggers, and specific caution groups) are not supported by the provided label excerpts for this specific product. Only a few general statements about GI side effects and that the product can be taken with or without food are partially consistent with label text.
Category Scores
Accurate Statements
Aspirin and Extended-Release Dipyridamole capsules can be administered with or without food.
Label Section 2 — “can be administered with or without food.”
GI side effects may include stomach pain, heartburn, nausea, vomiting, and gross GI bleeding.
Label Section 5.1 — “GI side effects include stomach pain, heartburn, nausea, vomiting, and gross GI bleeding…”
Aspirin and extended-release dipyridamole increases the risk of bleeding and contains aspirin (so it is associated with GI bleeding/ulcer-related concerns).
Label Section 5.1 — “Aspirin and extended-release dipyridamole increases the risk of bleeding.” and “Peptic Ulcer Disease… Avoid using aspirin in patients with a history of active peptic ulcer disease…”
Unsupported Statements
Taking aspirin before food increases the chance of stomach irritation.
The provided label does not state that timing relative to food changes the risk of stomach irritation for this product.
Aspirin taken without food increases the risk of stomach ulcers or bleeding.
The provided label excerpt does not link risk of ulcers/bleeding to taking the product without food.
Taking aspirin with food can reduce stomach upset in many people when used for pain or fever at typical OTC doses.
The label excerpt does not support OTC pain/fever use for this product, nor does it state that taking with food reduces stomach upset.
Taking aspirin with a full glass of water can reduce stomach upset in many people when used for pain or fever at typical OTC doses.
The provided label excerpt does not mention full glass of water or stomach-upset reduction from such administration.
For heart or stroke prevention, people should follow prescriber instructions regarding whether aspirin is taken consistently at a certain time and with or without food based on tolerance and other medications.
The provided label excerpt does not describe such instructions regarding timing consistency or tolerance-based food decisions.
There is no universal timing rule for how long before eating to take aspirin.
The provided label excerpt does not discuss a timing-before-eating rule.
Many people choose to take aspirin shortly before a meal or with a meal for comfort rather than well before eating.
This is not stated in the provided label excerpts.
If burning, nausea, or stomach pain occurs after taking aspirin before food, switching to taking it with food may help.
The label excerpt does not provide a management step that switching from before-food to with-food would help.
Taking aspirin before meals can cause heartburn or indigestion.
While heartburn can be a GI side effect (label), the provided label excerpt does not attribute it specifically to taking before meals.
Taking aspirin before meals can cause nausea.
Nausea is listed as a possible GI side effect, but the label excerpt does not connect nausea specifically to before-meal dosing.
Taking aspirin before meals can cause stomach pain.
Stomach pain is listed as a possible GI side effect, but the label excerpt does not connect it specifically to before-meal dosing.
People with a history of stomach ulcers or GI bleeding should be extra cautious about taking aspirin before eating.
The label excerpt says to avoid aspirin in patients with history of active peptic ulcer disease, but it does not specify “before eating” or “extra cautious when taking before eating.”
People with severe acid reflux or frequent stomach irritation should be extra cautious about taking aspirin before eating.
The provided label excerpt does not specify acid reflux or frequent stomach irritation as a timing-related caution.
People with bleeding disorders should be extra cautious about taking aspirin before eating.
The label excerpt does not include this timing-specific recommendation for bleeding disorders.
Taking aspirin before eating warrants extra caution if the person takes blood thinners such as warfarin, apixaban, rivaroxaban, or dabigatran.
The label excerpt indicates increased bleeding risk with anticoagulants/antiplatelets, but it does not list these specific agents and does not frame the caution as specifically “before eating.”
Taking aspirin before eating warrants extra caution if the person takes other medicines that increase bleeding risk.
The label excerpt supports increased bleeding risk with other drugs that increase bleeding risk, but does not specify this as “before eating.”
Taking aspirin before eating warrants extra caution if the person takes other NSAIDs such as ibuprofen or naproxen at the same time.
The label excerpt mentions chronic use of NSAIDs as a bleeding risk factor, but does not specifically advise against ibuprofen/naproxen “at the same time” nor tie it to “before eating.”
People with aspirin allergy or asthma that worsens with aspirin/NSAIDs should be extra cautious about taking aspirin before eating.
The label contraindicates aspirin in NSAID allergy and asthma/rhinitis/nasal polyps syndrome, but the label excerpt does not provide a timing-based “extra cautious about taking before eating” statement.
Black or tarry stools after taking aspirin warrant urgent medical care.
The label excerpt does not provide an urgent-care instruction tied to black/tarry stools.
Vomiting blood after taking aspirin warrants urgent medical care.
The label excerpt does not provide an urgent-care instruction tied to vomiting blood.
Severe stomach pain after taking aspirin warrants urgent medical care.
The label excerpt indicates GI side effects and to inform patients about signs/symptoms and what steps to take, but the provided excerpt does not define “urgent medical care” thresholds.
Plain water should be used when taking aspirin.
The provided label excerpt does not specify what liquid to use.
Taking aspirin with food is usually better than relying on buffering methods.
No buffering-method comparison is present in the provided label excerpt.
Antacids may help symptoms for some people taking aspirin.
No statement about antacids helping aspirin GI symptoms is included in the provided label excerpt.
Antacids do not remove aspirin’s effect on bleeding or ulcer risk.
No antacid-specific statements are present in the provided label excerpt.
Contradictions
Important Omissions
Clarification that this product is indicated to reduce stroke risk in patients with TIA or completed ischemic stroke due to thrombosis (not for pain/fever).
Importance:
Moderate
For contraindications: do not use in patients with hypersensitivity to components; aspirin contraindicated in NSAID allergy and in asthma/rhinitis/nasal polyps syndrome; do not use in children/teenagers with viral infections due to Reye syndrome.
Importance:
Moderate
For bleeding risk: counsel about GI side effects signs/symptoms and steps to take if they occur (general instruction), and avoid aspirin in patients with history of active peptic ulcer disease.
Importance:
Moderate
Administration instruction for this product: swallow capsules whole without chewing; recommended dosing is one capsule orally twice daily (morning and evening).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Several claims provide potentially actionable guidance (food timing changes, urgent-care triggers, antacid effectiveness, and specific drug/condition caution lists) that are not supported by the provided label excerpts for this product. While the label does confirm increased bleeding risk and GI side effects, the unsupported timing-specific and urgency/management assertions could mislead patient behavior.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
Yes |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Moderate |
Recommendation
Mostly Not Aligned
Primary Issue
The response includes many timing-specific and OTC-pain/fever-oriented statements (and antacid/urgency guidance) that are not supported by the provided FDA label excerpts for Aspirin and Extended-Release Dipyridamole Capsules.
Suggested Improvement
Limit claims to label-supported information: indication (stroke risk reduction in TIA/completed ischemic stroke due to thrombosis), dosing (capsule twice daily; swallow whole; with or without food), contraindications, and label-listed GI side effects and bleeding risk counsel without adding unsupported before-meal/urgent-care/antacid-effect assertions.